NCT05038358View on ClinicalTrials.gov

Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

September 30, 2028

Study Completion Date

December 31, 2030

Conditions
Primary TumorColon Tumor
Trial Locations (1)

38043

RECRUITING

University Hospital of Grenoble Alpes, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT05038358 - Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms | Biotech Hunter | Biotech Hunter